Skip to main content
SpringerLink
Log in

Inhibiting PI3K/Akt pathway increases DNA damage of cervical carcinoma HeLa cells by drug radiosensitization

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

This study examined the role of PI3K/Akt pathway in radiosensitization of DNA damage of cervical carcinoma cells. The 50% inhibition concentration (IC50) of cisplatin and docetaxel in HeLa cells was detected by Mono-nuclear cell direct cytotoxicity assay (MTT) in vitro. HeLa cells were treated by cisplatin/docetaxel of 10 percent of IC20 alone or combined with LY294002 for 24 h, and then radiated by different doses of X-ray. The cell survival ratio was obtained by means of clone formation. One-hit multi-target model was fitted to the cell survival curve to calculate dose quasithreshold (Dq), mean lethal dose (D0), 2Gy survival fraction (SF2) and sensitization enhancement ratio (SER). The pAkt and total Akt expression was detected by Western blotting and DNA damage by neutro-comet electrophoresis. The HeLa cells were randomly divided into 7 groups in terms of different treatments: Control; radiation treatment (RT) group; LY294002+RT group; cisplatin+RT group; docetaxel+RT group; LY294002+cisplatin+RT group; LY294002+docetaxel+RT group. The apoptosis ratio of each group was measured by flow cytometry. The results showed that docetaxel and cisplatin significantly enhanced the phosphorylation of Akt in radiation-treated HeLa cells. The Dq, D0 and SF2 in LY294002-contained groups were lower than those in docetaxel or cisplatin+RT group. The SER in the LY294002+docetaxel+RT group was 1.35 times that of the docetaxel+RT group, and that in the LY294002+cisplatin+RT group 1.26 times that of the cisplatin+RT group. The Comet electrophoresis showed that tail distance in the LY294002+cisplatin+RT group or LY294002+docetaxel+ RT group was longer than in the cisplatin+RT group or docetaxel+RT group. The apoptosis ratio in the LY294002+cisplatin+RT group or LY294002+docetaxel +RT group was higher than in the cisplatin+RT group or docetaxel+RT group. It was concluded that inhibiting PI3K/Akt pathway can increase the effect of docetaxel and cisplatin on the radiosensitivity of HeLa cells and DNA damage resulted from radiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jin ZH, Kurosu T, Yamaguchi M, et al. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. Oncogene, 2005,24(12):1973–1981

    Article  CAS  PubMed  Google Scholar 

  2. Cheng JQ, Lindsley CW, Cheng GZ, et al. The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene, 2005,24(50):7482–7492

    Article  CAS  PubMed  Google Scholar 

  3. Opel D, Westhoff MA, Bender A, et al. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Cancer Res, 2008,68(15):6271–6280

    Article  CAS  PubMed  Google Scholar 

  4. Okumura E, Fukuhara T, Yoshida H, et al. Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. Nat Cell Biol, 2002,4(2): 111–116

    Article  CAS  PubMed  Google Scholar 

  5. Han R. The application of quantitative analysis of drugs’synergetic and antagonism effect. In: Zhou TC, Han R, Xu B. Chemoprevention and pharmacotherapy of tumor. Beijing: Peking Union Medical College Press, 1991:315–320

    Google Scholar 

  6. Tan J, Hallahan DE. Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response. Cancer Res, 2003, 63(22):7663–7667

    CAS  PubMed  Google Scholar 

  7. Kandel ES, Skeen J, Majewski N, et al. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol, 2002,22(22):7831–7841

    Article  CAS  PubMed  Google Scholar 

  8. Riesterer O, Tenzer A, Zingg D, et al. Novel radiosensitizers for locally advanced epithelial tumors: inhibition of the PI3K/Akt survival pathway in tumor cells and in tumor-associated endothelial cells as a novel treatment strategy? Int J Radiat Oncol Biol Phys, 2004,58(2): 361–368

    CAS  PubMed  Google Scholar 

  9. Cordes N, van Beuningen D. Arrest of human lung fibroblasts in G2 phase after irradiation is regulated by converging phosphatidylinositol-3 kinase and beta1-integrin signaling in vitro. Int J Radiat Oncol Biol Phys, 2004,58(2):453–462

    CAS  PubMed  Google Scholar 

  10. Kim IA, Bae SS, Fernandes A, et al. Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines. Cancer Res, 2005,65(17):7902–7910

    CAS  PubMed  Google Scholar 

  11. Gupta AK, Cerniglia GJ, Mick R, et al. Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002. Int J Radiat Oncol Biol Phys, 2003,56(3):846–853

    CAS  PubMed  Google Scholar 

  12. Lee DF, Kuo HP, Chen CT, et al. IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance. Int J Mol Med, 2008,22(5):633–638

    CAS  PubMed  Google Scholar 

  13. Sauer S, Bruno L, Hertweck A, et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A, 2008,105(22): 7797–7802

    Article  CAS  PubMed  Google Scholar 

  14. Steinberg R, Harari OA, Lidington EA, et al. A protein kinase Cepsilon-anti-apoptotic kinase signaling complex protects human vascular endothelial cells against apoptosis through induction of Bcl-2. J Biol Chem, 2007,282(44):32288–32297

    Article  CAS  PubMed  Google Scholar 

  15. Aziz MH, Nihal M, Fu VX, et al. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther, 2006,5(5):1335–1341

    Article  CAS  PubMed  Google Scholar 

  16. Clark AS, West K, Streicher S, et al. Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther, 2002,1(9):707–717

    CAS  PubMed  Google Scholar 

  17. Canguilhem B, Pradines A, Baudouin C, et al. RhoB protects human keratinocytes from UVB-induced apoptosis through epidermal growth factor receptor signaling. J Biol Chem, 2005,280(52):43257–43263

    Article  CAS  PubMed  Google Scholar 

  18. Shen Y, Mi FS. Tumor Radiation Biology. Beijing: Chinese Medicine Science Press, 2002,52–78

    Google Scholar 

  19. Yin WB, Gu XZ, Xu GZ, et al. Radiation Oncology. The 4th edition. Beijing: Chinese Xiehe Medical University Press, 2008,232–239

    Google Scholar 

  20. Fairbairn DW, Olive PL, O’Neill KL. The comet assay: a comprehensive review. Mutat Res, 1995,339(1):37–59

    CAS  PubMed  Google Scholar 

  21. Singh NP, Stephens RE. Microgel electrophoresis: sensitivity, mechanisms, and DNA electrostretching. Mutat Res, 1997,383(2):167–175

    CAS  PubMed  Google Scholar 

  22. Okayasu R, Takakura K, Poole S, et al. Radiosensitization of normal human cells by LY294002: Cell killing and the rejoining of DNA and interphase chromosome breaks. J Radiat Res (Tokyo), 2003,44(4):329–333

    Article  CAS  Google Scholar 

  23. Friedmann B, Caplin M, Hartley JA, et al. Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839). Clin Cancer Res, 2004,10(19): 6476–6486

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Shu Xia  (夏 曙), Shiying Yu  (于世英), Qiang Fu  (付 强), Fei Liu  (刘 飞), Wei Zheng  (郑 微) & Xiugen Fu  (付秀根)

  2. Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Yin Zhao  (赵 茵)

Authors
  1. Shu Xia  (夏 曙)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shiying Yu  (于世英)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qiang Fu  (付 强)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fei Liu  (刘 飞)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wei Zheng  (郑 微)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiugen Fu  (付秀根)
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yin Zhao  (赵 茵)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yin Zhao  (赵 茵).

Additional information

This project was supported by grants from the Hubei Province Natural Sciences Foundation (No.2008cdb133) and Science Foundation for The Youth Scholars of Ministry of Education of China (No.200804871034).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xia, S., Yu, S., Fu, Q. et al. Inhibiting PI3K/Akt pathway increases DNA damage of cervical carcinoma HeLa cells by drug radiosensitization. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 30, 360–364 (2010). https://doi.org/10.1007/s11596-010-0357-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-010-0357-0

Key words

Search

Navigation